Research highlights the diagnostic value of CD303 in BPDCN, with studies showing its expression in nearly all cases examined, thus providing high sensitivity and specificity [58,59,60]. This evidence concerns the gene CLEC4C and CD4+/CD56+ hematodermic neoplasm.